Authors

• Emil Andreas Asprusten (ORCID: https://orcid.org/0009-0005-9075-3296)
• Russell L. Scott (ORCID: https://orcid.org/0000-0003-2987-5380)
• Ann Marie Návar (ORCID: https://orcid.org/0000-0002-6197-9860)
• Christie Mitchell Ballantyne (ORCID: https://orcid.org/0000-0002-6432-1730)
• Samar Froman
• Laura Gellis (ORCID: https://orcid.org/0000-0003-4070-4478)
• Puja Banka (ORCID: https://orcid.org/0000-0002-1407-2705)
• Erik S.G. Stroes (ORCID: https://orcid.org/0000-0001-9555-6260)
• Fan Wang (ORCID: https://orcid.org/0000-0002-9869-9504)
• Alberico L. Catapano (ORCID: https://orcid.org/0000-0002-7593-2094)
• Jean-Claude Tardif
• Geraldine Mendizabal

Institutions

• Oslo University Hospital (NO)
• Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
• Baylor College of Medicine (US)
• University of Milan (IT)
• Montreal Heart Institute (CA)
• Munroe Regional Medical Center (US)
• MultiMedica (IT)
• Amsterdam University Medical Centers (NL)
• Université de Montréal (CA)
• The University of Texas Southwestern Medical Center (US)
• University of Amsterdam (NL)

Publication Details

Journal

JAMA

Published

2025-11-09

DOI

https://doi.org/10.1001/jama.2025.20620

Citations

15

Primary Topic

Lipoproteins and Cardiovascular Health

Type

article

Field-Weighted Citation Impact

30.10